Cybin Inc. (CYBN)
NYSEAMERICAN: CYBN · Real-Time Price · USD
9.09
-0.24 (-2.57%)
At close: Feb 21, 2025, 4:00 PM
9.01
-0.08 (-0.88%)
After-hours: Feb 21, 2025, 7:58 PM EST
Cybin Market Cap
Cybin has a market cap or net worth of $191.22 million as of February 21, 2025. Its market cap has increased by 35.15% in one year.
Market Cap
191.22M
Enterprise Value
96.49M
1-Year Change
35.15%
Ranking
Category
Stock Price
$9.09
Market Cap Chart
Since November 11, 2020, Cybin's market cap has increased from $91.10M to $191.22M, an increase of 109.91%. That is a compound annual growth rate of 18.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2025 | 196.27M | 11.25% |
| Dec 31, 2024 | 176.41M | 4.62% |
| Dec 29, 2023 | 168.63M | 199.71% |
| Dec 30, 2022 | 56.26M | -72.57% |
| Dec 31, 2021 | 205.14M | 4.86% |
| Dec 31, 2020 | 195.64M | 114.76% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.61B |
| UnitedHealth Group | 462.61B |
| Johnson & Johnson | 384.35B |
| Novo Nordisk | 370.84B |
| AbbVie | 354.64B |
| Abbott Laboratories | 230.97B |
| AstraZeneca | 227.07B |
| Merck & Co. | 221.80B |